MSD has signed an agreement with Variational AI to use its generative AI (genAI) platform Enki in the discovery of new small-molecule medicines. Vancouver, Canada-based Variational – which emerged in ...

MicroAlgo (NASDAQ: MLGO) faces significant challenges, highlighted by a concerning 1.1% return on capital employed (ROCE) and a 100% decline in stock value over three years. Despite recent ...